These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18940813)

  • 21. The dual specificity JKAP specifically activates the c-Jun N-terminal kinase pathway.
    Chen AJ; Zhou G; Juan T; Colicos SM; Cannon JP; Cabriera-Hansen M; Meyer CF; Jurecic R; Copeland NG; Gilbert DJ; Jenkins NA; Fletcher F; Tan TH; Belmont JW
    J Biol Chem; 2002 Sep; 277(39):36592-601. PubMed ID: 12138158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells.
    Eguchi R; Fujimori Y; Takeda H; Tabata C; Ohta T; Kuribayashi K; Fukuoka K; Nakano T
    J Cell Physiol; 2011 Mar; 226(3):762-8. PubMed ID: 20799280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dimerization through the catalytic domain is essential for MEKK2 activation.
    Cheng J; Yu L; Zhang D; Huang Q; Spencer D; Su B
    J Biol Chem; 2005 Apr; 280(14):13477-82. PubMed ID: 15695508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia.
    Waetzig V; Czeloth K; Hidding U; Mielke K; Kanzow M; Brecht S; Goetz M; Lucius R; Herdegen T; Hanisch UK
    Glia; 2005 May; 50(3):235-46. PubMed ID: 15739188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The crystal structure of JNK2 reveals conformational flexibility in the MAP kinase insert and indicates its involvement in the regulation of catalytic activity.
    Shaw D; Wang SM; Villaseñor AG; Tsing S; Walter D; Browner MF; Barnett J; Kuglstatter A
    J Mol Biol; 2008 Nov; 383(4):885-93. PubMed ID: 18801372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JNK2 Is Required for the Tumorigenic Properties of Melanoma Cells.
    Du L; Anderson A; Nguyen K; Ojeda SS; Ortiz-Rivera I; Nguyen TN; Zhang T; Kaoud TS; Gray NS; Dalby KN; Tsai KY
    ACS Chem Biol; 2019 Jul; 14(7):1426-1435. PubMed ID: 31063355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct inhibition of c-Jun N-terminal kinase in sympathetic neurones prevents c-jun promoter activation and NGF withdrawal-induced death.
    Eilers A; Whitfield J; Shah B; Spadoni C; Desmond H; Ham J
    J Neurochem; 2001 Mar; 76(5):1439-54. PubMed ID: 11238729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent protective and destructive signaling of JNK2 in neuroblastoma cells.
    Waetzig V; Wacker U; Haeusgen W; Björkblom B; Courtney MJ; Coffey ET; Herdegen T
    Cell Signal; 2009 Jun; 21(6):873-80. PubMed ID: 19385049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation.
    Khokhlatchev AV; Canagarajah B; Wilsbacher J; Robinson M; Atkinson M; Goldsmith E; Cobb MH
    Cell; 1998 May; 93(4):605-15. PubMed ID: 9604935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the activity of MEK kinase 1 (MEKK1) by autophosphorylation within the kinase activation domain.
    Deak JC; Templeton DJ
    Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):185-92. PubMed ID: 9078260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse 3-phosphoinositide-dependent protein kinase-1 undergoes dimerization and trans-phosphorylation in the activation loop.
    Wick MJ; Ramos FJ; Chen H; Quon MJ; Dong LQ; Liu F
    J Biol Chem; 2003 Oct; 278(44):42913-9. PubMed ID: 12923190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of phosphatidylinositol 3-kinase and c-Jun-N-terminal kinase cascades enhances NF-kappaB-dependent gene transcription in BCG-stimulated macrophages through promotion of p65/p300 binding.
    Darieva Z; Lasunskaia EB; Campos MN; Kipnis TL; Da Silva WD
    J Leukoc Biol; 2004 Apr; 75(4):689-97. PubMed ID: 14742634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin stimulates activation of c-jun N-terminal kinase (JNK).
    Schwertfeger KL; Hunter S; Heasley LE; Levresse V; Leon RP; DeGregori J; Anderson SM
    Mol Endocrinol; 2000 Oct; 14(10):1592-602. PubMed ID: 11043575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human mitogen-activated protein kinase kinase kinase mediates the stress-induced activation of mitogen-activated protein kinase cascades.
    Chan-Hui PY; Weaver R
    Biochem J; 1998 Dec; 336 ( Pt 3)(Pt 3):599-609. PubMed ID: 9841871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of mitogen-activated protein kinase pathways used by interleukin 1 in tissues in vivo: activation of hepatic c-Jun N-terminal kinases 1 and 2, and mitogen-activated protein kinase kinases 4 and 7.
    Finch A; Davis W; Carter WG; Saklatvala J
    Biochem J; 2001 Jan; 353(Pt 2):275-81. PubMed ID: 11139391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211.
    Miller AL; Webb MS; Copik AJ; Wang Y; Johnson BH; Kumar R; Thompson EB
    Mol Endocrinol; 2005 Jun; 19(6):1569-83. PubMed ID: 15817653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation.
    Sabapathy K; Hochedlinger K; Nam SY; Bauer A; Karin M; Wagner EF
    Mol Cell; 2004 Sep; 15(5):713-25. PubMed ID: 15350216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour necrosis factor-induced activation of c-Jun N-terminal kinase is sensitive to caspase-dependent modulation while activation of mitogen-activated protein kinase (MAPK) or p38 MAPK is not.
    Mohamed AA; Jupp OJ; Anderson HM; Littlejohn AF; Vandenabeele P; MacEwan DJ
    Biochem J; 2002 Aug; 366(Pt 1):145-55. PubMed ID: 11996667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways.
    Gu J; Tamura M; Yamada KM
    J Cell Biol; 1998 Nov; 143(5):1375-83. PubMed ID: 9832564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
    Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
    J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.